Delivery Order #SPE2D326F6351

Fresenius Kabi Delivery Order for Diphenhydramine Pharmaceutical Supply

This award represents a delivery order contract placed under an existing indefinite delivery indefinite quantity (IDIQ) contract held by Fresenius Kabi, LLC. Fresenius Kabi, a well-established pharmaceutical manufacturing company, is contracted to supply a specific formulation of diphenhydramine (50 mg/ml vial), a critical medical product used for various health treatments. The contract supports the U.S. Department of Defense’s medical supply chain, ensuring timely availability of essential pharmaceuticals for military and healthcare operations. The scope of work is narrowly focused on the production and delivery of this particular drug product, maintaining the readiness and quality standards required by the DoD. This delivery order is a follow-up action stemming from a prior competitive award of a long-term IDIQ contract to Fresenius Kabi, highlighting their role in securing critical injectable pharmaceuticals. The contract was awarded through the IDIQ vehicle to allow efficient procurement under existing terms. The performance period for this delivery order is for a short, specific timeframe within the year 2026. No key subcontractors or solicitation details are associated specifically with this delivery order. This contract underscores the ongoing collaboration between Fresenius Kabi and the Department of Defense to maintain a reliable supply of crucial medical products through a responsible and established procurement mechanism.

Description

4570916479!DIPHENHYDRAMINE 50 MG/ML VIALML

View original record